Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Multi-Disciplinary Approach to Diagnosis and Treatment of Radionecrosis in Malignant Gliomas and Cerebral Metastases.
Mangesius J, Mangesius S, Demetz M, Uprimny C, Di Santo G, Galijasevic M, Minasch D, Gizewski ER, Ganswindt U, Virgolini I, Thomé C, Freyschlag CF, Kerschbaumer J. Mangesius J, et al. Among authors: di santo g. Cancers (Basel). 2022 Dec 19;14(24):6264. doi: 10.3390/cancers14246264. Cancers (Basel). 2022. PMID: 36551750 Free PMC article. Review.
Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the 68Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer.
von Guggenberg E, Uprimny C, Klinger M, Warwitz B, Sviridenko A, Bayerschmidt S, di Santo G, Virgolini IJ. von Guggenberg E, et al. Among authors: di santo g. J Nucl Med. 2023 Jun;64(6):859-862. doi: 10.2967/jnumed.122.264977. Epub 2023 Jan 19. J Nucl Med. 2023. PMID: 36657979 Free article.
Imaging Fibrosis.
Sviridenko A, di Santo G, Virgolini I. Sviridenko A, et al. Among authors: di santo g. PET Clin. 2023 Jul;18(3):381-388. doi: 10.1016/j.cpet.2023.02.004. Epub 2023 Mar 27. PET Clin. 2023. PMID: 36990946 Review.
Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study.
Kafka M, Horninger A, di Santo G, Virgolini I, Neuwirt H, Unterrainer LM, Kunte SC, Deiss E, Paffenholz P, Heidenreich A, Rasul S, Einspieler H, Shariat SF, Rajwa P, Dozauer R, Tsaur I, Medlock E, Rölz N, Rausch S, la Fougère C, Trautwein N, Roesch MC, Merseburger AS, Zattoni F, Sepulcri M, Ladurner M, Bektic J, Gandaglia G, Horninger W, Heidegger I. Kafka M, et al. Among authors: di santo g. Eur Urol Oncol. 2024 Jun;7(3):421-429. doi: 10.1016/j.euo.2023.07.018. Epub 2023 Aug 19. Eur Urol Oncol. 2024. PMID: 37604763 Free article.
Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer.
Santo G, Di Santo G, Sviridenko A, Bayerschmidt S, Wirth L, Scherbauer F, Lehmann P, von Guggenberg E, Decristoforo C, Heidegger-Pircher I, Bektic J, Virgolini I. Santo G, et al. Among authors: di santo g. Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):354-365. doi: 10.1007/s00259-024-06905-5. Epub 2024 Sep 3. Eur J Nucl Med Mol Imaging. 2024. PMID: 39225826 Free PMC article.
Radiopharmaceutical formulation and preliminary clinical dosimetry of [177Lu]Lu-DOTA-MGS5 for application in peptide receptor radionuclide therapy.
Zavvar TS, Hörmann AA, Konijnenberg M, Kraihammer M, Mair C, Kronthaler A, Joosten L, Laverman P, Gruber L, di Santo G, Decristoforo C, Virgolini I, von Guggenberg E. Zavvar TS, et al. Among authors: di santo g. Eur J Nucl Med Mol Imaging. 2024 Dec 7. doi: 10.1007/s00259-024-06979-1. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39643727
62 results